Log in to save to my catalogue

56371 The Signaling Axis of Tumor Suppressor LKB1 in Triple Negative Breast Cancer

56371 The Signaling Axis of Tumor Suppressor LKB1 in Triple Negative Breast Cancer

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_45877e2226b24f18aee23afd029c2a76

56371 The Signaling Axis of Tumor Suppressor LKB1 in Triple Negative Breast Cancer

About this item

Full title

56371 The Signaling Axis of Tumor Suppressor LKB1 in Triple Negative Breast Cancer

Publisher

Cambridge, UK: Cambridge University Press

Journal title

Journal of clinical and translational science, 2021-03, Vol.5 (s1), p.15-15

Language

English

Formats

Publication information

Publisher

Cambridge, UK: Cambridge University Press

More information

Scope and Contents

Contents

ABSTRACT IMPACT: Identifying an important pathway in treatment resistant TNBC will allow for the future development of clinical therapeutics specific for this disease. OBJECTIVES/GOALS: Triple Negative Breast Cancer (TNBC) is a subtype of breast cancer characterized by negative expression of estrogen receptor, progesterone receptor, and HER2/neu am...

Alternative Titles

Full title

56371 The Signaling Axis of Tumor Suppressor LKB1 in Triple Negative Breast Cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_45877e2226b24f18aee23afd029c2a76

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_45877e2226b24f18aee23afd029c2a76

Other Identifiers

ISSN

2059-8661

E-ISSN

2059-8661

DOI

10.1017/cts.2021.442

How to access this item